Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2025-12-25 @ 2:33 PM
Study NCT ID:
NCT03491150
Status:
TERMINATED
Last Update Posted:
2020-07-13
First Post:
2018-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-15
First Submit QC Date:
None
Study First Post Date:
2018-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-05-26
Results First Submit QC Date:
None
Results First Post Date:
2020-06-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-25
Last Update Post Date:
2020-07-13
Last Update Post Date Type:
ACTUAL